Literature DB >> 8976285

Inflammation and growth factors.

S M Wahl1.   

Abstract

PURPOSE: Pathways of inflammation culminating in tissue repair and scarring are defined.
MATERIALS AND METHODS: Inflammatory responses were induced in vitro and in vivo to monitor the mechanisms of leukocyte activation, the inflammatory products generated, the resolution of the response and tissue repair.
RESULTS: Recruitment and activation of circulating leukocytes at sites of trauma and inflammation are essential to debridement, clearance of infectious organisms and repair of tissue injury. Once activated, infiltrating leukocytes generate a plethora of inflammatory mediators important in host defense. However, failure to clear the original stimulus and resolve the inflammatory response results in persistent release of these mediators, including cytokines, enzymes, eicosanoids, and reactive nitrogen and oxygen intermediates, which can cause tissue damage. Overabundant matrix generation during the chronic repair process may cause fibro-obstructive pathology.
CONCLUSIONS: Disruption of these pathways, including leukocyte recruitment, may have therapeutic efficacy.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8976285

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  3 in total

1.  CT features of lung scar cancer.

Authors:  Feng Gao; Xiaojun Ge; Ming Li; Xiangpeng Zheng; Li Xiao; Guozhen Zhang; Yanqing Hua
Journal:  J Thorac Dis       Date:  2015-03       Impact factor: 2.895

2.  US Imaging in Peyronie's Disease.

Authors:  Kiriaki Kalokairinou; Charalampos Konstantinidis; Marilena Domazou; Theodoros Kalogeropoulos; Prodromos Kosmidis; Aristomenis Gekas
Journal:  J Clin Imaging Sci       Date:  2012-10-31

Review 3.  New discoveries in the basic science understanding of Peyronie's disease.

Authors:  Mark Jalkut; Nestor Gonzalez-Cadavid; Jacob Rajfer
Journal:  Curr Urol Rep       Date:  2004-12       Impact factor: 2.862

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.